Isolation of Exstraintestinal Pathogenic E.coli from ostcholecystectomic Samples and their Antimicrobial profile in Georgia
pdf

How to Cite

Pachkoria, E., Vashakidze, E., Megrelishvili, T., & Tevzadze, L. (2013). Isolation of Exstraintestinal Pathogenic E.coli from ostcholecystectomic Samples and their Antimicrobial profile in Georgia. Collection of Scientific Works of Tbilisi State Medical University, 47, 125–127. Retrieved from https://journals.4science.ge/index.php/CSW/article/view/3362

Abstract

Since 2009, we have been studying infections caused by pathogenic E. coli in Georgia (STEC infection and HUS syndrome). The work discusses the role of pathogenic E. coli and EBL strains in the development of extraintestinal abdominal pathology - chronic calculous cholecystitis. The frequency of highly resistant, extended-spectrum beta-lactamase-producing E. Coli - (ESBL) strains has increased worldwide. To determine the specific role of E. Coli in the development of chronic calculous cholecystitis, bacteriological analysis of 130 postoperative gallbladder tissues was performed and the sensitivity of the isolated cultures to antibiotics is currently being studied. Genome analysis of ESBL strains (MISEQ —Illumina Platform) (NCDC) is currently underway. Gallbladder tissue from 130 patients was examined. 28 cultures (22%) were isolated, including EE.COli-9 cases (32%); 6 of them were ESBL strains. The dominance of E.Coli-strains was revealed compared to other pathogens. We studied the sensitivity of the isolated E.Coli strains to antibiotics. ESBL-producing E.Coli strains were resistant to penicillin and cephalosporin antibiotics, and resistance to ciprofloxacin and imipenem was also established. Thus, in the bacteriological study of post-cholecystectomy material, in various gallbladder pathologies, the presence of ESBL-producing E.Coli strains indicates the circulation of highly resistant E.Coli strains in Georgia.

pdf

References

Ho PL. Poon WW,Loke SL, et al. Community emergence of CTX –M type extend-spectrum beta-lactamases among urinary Escherichia coli from women. J Antimicrob chemother 2007; 60:140.

Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, RiceLB, et al. Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases. Antimicrob Agents Chemother 2003; 47:3554-60.

Paterson DL, Bonomo RA. Extended-spectrum a-lactamases: a clinical update. Clin Microbiol Rev 2005; 18:657-86.

Doi Y, Park YS,Rivera Jl, et al. Community-associated extended-spectrum B-lactamase-producing Escherichia coli infection in the United States. Clin.infec.Dis., 2013; 56:41

Totsika M, Beatson SA, Sarkar S, Phan M-D, Petty NK, et al. (2011) Insights into a Multidrug Resistant Escherichia coli Pathogen of the Globally Disseminated ST131 Lineage: Genome Analysis and Virulence Mechanisms. PLoS ONE 6(10): e26578. doi:10.1371/journal.pone.0026578

Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement ed. CLSI document M100-S20. Wayne, PA: CLSI; 2010.

Downloads

Download data is not yet available.